THAR (STOCKS)
Tharimmune, Inc. Common Stock
$4.420000
-0.240000 (-5.15%)
Prev close: $4.660000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Mark Wendland
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $193.55M
- Employees
- 3
- P/E (TTM)
- -1.19
- P/B (TTM)
- 5.46
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2023 (Q4)
|
$-10.70 | $-19.13 | +8.4300 | +44.08% |
|
Sep 2023 (Q3)
|
$-41.25 | $-22.95 | -18.3000 | -79.74% |
|
Jun 2023 (Q2)
|
$-60.00 | $-61.20 | +1.2000 | +1.96% |
|
Mar 2023 (Q1)
|
$-86.25 | $-42.08 | -44.1750 | -104.99% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $19.63K |
| Operating Expenses | $10.34M |
| Research and Development | $3.50M |
| Other Operating Expenses | $6.84M |
| Operating Income/Loss | -$10.34M |
| Income/Loss From Continuing Operations After Tax | -$10.32M |
| Income/Loss From Continuing Operations Before Tax | -$10.32M |
| Net Income/Loss | -$10.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.68 |
| Diluted Earnings Per Share | -$3.68 |
| Basic Average Shares | 4,073,811 |
| Diluted Average Shares | 4,073,811 |
| Assets | $7.70M |
| Current Assets | $7.70M |
| Noncurrent Assets | $0.00 |
| Liabilities | $1.54M |
| Current Liabilities | $1.54M |
| Accounts Payable | $659.25K |
| Other Current Liabilities | $885.30K |
| Noncurrent Liabilities | $0.00 |
| Equity | $6.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.15M |
| Liabilities And Equity | $7.70M |
| Net Cash Flow From Operating Activities | -$8.72M |
| Net Cash Flow From Operating Activities, Continuing | -$8.72M |
| Net Cash Flow From Investing Activities | -$2.84M |
| Net Cash Flow From Investing Activities, Continuing | -$2.84M |
| Net Cash Flow From Financing Activities | $11.56M |
| Net Cash Flow From Financing Activities, Continuing | $11.56M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$10.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.32M |
| Other Comprehensive Income/Loss | $0.00 |